|
NFIA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.54639992319983E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.5686000255406E-09 |
| Normal-vs-Stage2 |
1.871930E-02 |
| Normal-vs-Stage3 |
3.877000E-01 |
| Normal-vs-Stage4 |
5.052400E-01 |
| Stage1-vs-Stage2 |
7.238200E-01 |
| Stage1-vs-Stage3 |
2.696200E-02 |
| Stage1-vs-Stage4 |
1.427190E-01 |
| Stage2-vs-Stage3 |
1.852360E-01 |
| Stage2-vs-Stage4 |
2.687600E-01 |
| Stage3-vs-Stage4 |
9.970600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.45489978240232E-10 |
| Normal-vs-AfricanAmerican |
5.169800E-04 |
| Normal-vs-Asian |
4.910200E-01 |
| Caucasian-vs-AfricanAmerican |
1.201770E-01 |
| Caucasian-vs-Asian |
2.930300E-02 |
| AfricanAmerican-vs-Asian |
3.807800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.58390017452371E-11 |
| Normal-vs-Female |
4.715200E-03 |
| Male-vs-Female |
3.322200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.252070E-02 |
| Normal-vs-Extreme_Weight |
9.12389999996321E-07 |
| Normal-vs-Obese |
4.64489999996154E-06 |
| Normal-vs-Extreme_Obese |
7.656100E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.470400E-01 |
| Normal_Weight-vs-Obese |
4.263400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.286200E-01 |
| Extreme_Weight-vs-Obese |
8.637600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.945200E-01 |
| Obese-vs-Extreme_Obese |
9.338000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.825600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.4992000025037E-08 |
| Normal-vs-Age(61-80Yrs) |
1.84829999971825E-07 |
| Normal-vs-Age(81-100Yrs) |
9.562600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.593600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.133800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.679420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.387250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.101600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.781400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.22124532708767E-15 |
| Normal-VS-Type2 PRCC |
5.883900E-02 |
| Normal-VS-KIRP CIMP |
2.52320000004858E-07 |
| Normal-VS-Unclassified PRCC |
3.043800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.92930000000968E-06 |
| Type1 PRCC-VS-KIRP CIMP |
<1E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
1.344800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.33500055033676E-10 |
| Type2 PRCC-VS-Unclassified PRCC |
6.468500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.52159951305464E-10 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.981500E-03 |
| Normal-vs-N1 |
7.034200E-01 |
| Normal-vs-N2 |
3.540400E-01 |
| N0-vs-N1 |
1.351370E-01 |
| N0-vs-N2 |
6.133400E-01 |
| N1-vs-N2 |
2.153800E-01 |
|
|
